Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Target Detachable Coils

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Target Detachable Coils see related information
Date Initiated by Firm June 06, 2016
Date Posted July 11, 2016
Recall Status1 Terminated 3 on March 03, 2017
Recall Number Z-2176-2016
Recall Event ID 74425
510(K)Number K113412  K153658  
Product Classification Device, neurovascular embolization - Product Code HCG
Product Target Detachable Coils:
TARGET 360 NANO 3MM X 6CM
MODEL Number:M0035443060


Neurology: Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Code Information MODEL Number: M0035443060:  Lot Number/Expiration Date: 18826753 31-Jan-19 18826606 31-Jan-19 18794421 31-Jan-19 18777349 31-Dec-18 18750808 31-Dec-18 18754448 31-Dec-18 18760112 31-Dec-18 18491003 31-Jul-18 18443198 30-Jun-18 18827047 31-Jan-19 18816704 31-Jan-19 18776301 31-Dec-18 18750603 31-Dec-18 18491065 31-Jul-18 18442058 30-Jun-18 18808498 31-Jan-19 18783540 31-Jan-19 18764659 31-Dec-18 18750193 31-Dec-18 18708724 30-Nov-18 18491096 31-Jul-18 18443258 30-Jun-18 18443228 30-Jun-18 18393950 31-May-18 18817367 31-Jan-19 18782584 31-Jan-19 18755514 31-Dec-18 18703469 30-Nov-18 18443018 30-Jun-18 18442958 30-Jun-18 18442538 30-Jun-18 18441728 30-Jun-18 18436622 30-Jun-18 18827341 31-Jan-19 18809086 31-Jan-19 18809674 31-Jan-19 18765615 31-Dec-18 18750398 31-Dec-18 18471007 31-Jul-18 18490724 31-Jul-18 18818030 31-Jan-19 18760113 31-Dec-18 18708786 30-Nov-18 18490972 31-Jul-18 18442508 30-Jun-18 18442268 30-Jun-18 18827194 31-Jan-19 18703264 30-Nov-18 18490910 31-Jul-18 18442568 30-Jun-18 18827488 31-Jan-19 18826900 31-Jan-19 18808792 31-Jan-19 18443048 30-Jun-18 19013252 30-Apr-19 19000510 30-Apr-19 18951824 31-Mar-19 18853836 28-Feb-19 19028176 30-Apr-19 18990655 30-Apr-19 19041022 31-May-19 19040295 31-May-19 19000572 30-Apr-19 18960708 31-Mar-19 18902391 28-Feb-19 19013163 30-Apr-19 19066272 31-May-19 19063700 31-May-19 18975258 30-Apr-19 18974821 30-Apr-19 18905927 31-Mar-19 19028296 30-Apr-19 19013074 30-Apr-19 18952060 31-Mar-19 18951116 31-Mar-19 18905896 28-Feb-19 18901749 28-Feb-19 18990624 30-Apr-19 18952296 31-Mar-19 19028056 30-Apr-19 19012985 30-Apr-19 18975695 30-Apr-19 18943458 31-Mar-19 18926529 31-Mar-19 18903033 28-Feb-19 19027936 30-Apr-19 19039567 31-May-19 19000541 30-Apr-19 18960301 31-Mar-19 18951588 31-Mar-19 18943981 31-Mar-19 18883033 28-Feb-19 18925429 31-Mar-19 18944504 31-Mar-19. 
Recalling Firm/
Manufacturer		 Stryker Neurovascular
47900 Bayside Pkwy
Fremont CA 94538-6515
For Additional Information Contact Geraldin Ahern
510-413-2593
Manufacturer Reason
for Recall		 Stryker Neurovascular has become aware that some units of Target Nano product do not have the intended stretch resistance. The sutures inside the coil that provide stretch resistance may have been damaged during manufacturing which can lead to an increased occurrence of coil stretching.
FDA Determined
Cause 2		 Process change control
Action Stryker Neurovascular sent an Urgent Medical Device Voluntary Recall letter dated June 3, 2016, to all affected customers via FED Ex. Letter includes recall letter, list of impacted lot numbers, customer acknowledgement form and frequently asked questions. Customers were instructed to immediately check their inventory. segregate the effected inventory in a secure location for return to Stryker, circulate the Field Safety Notice internally to all interested/affected parties. Inform Stryker if any of the subject devices have been distributed to other organizations. Customers were also instructed to complete the attached customer response form and return the completed form to their nominated Stryker Representative.
Quantity in Commerce 45,302 (8,188 in the U.S.) - total, all model numbers
Distribution Worldwide Distribution - US (nationwide) and Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italia, Japan,Latvia, Lebanon, Libyan Arab Jamahiriya, Lithuania, Luxembourg, Mexico,Netherlands, Norway, Peru, Philippines, Poland, Portugal, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Uruguay, and Vietnam.
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database 510(K)s with Product Code = HCG and Original Applicant = STRYKER NEUROVASCULAR
-
-